MACULAR POLYPOIDAL CHOROIDAL VASCULOPATHY (PCV)

Clinical trials for MACULAR POLYPOIDAL CHOROIDAL VASCULOPATHY (PCV) explained in plain language.

Never miss a new study

Get alerted when new MACULAR POLYPOIDAL CHOROIDAL VASCULOPATHY (PCV) trials appear

Sign up with your email to follow new studies for MACULAR POLYPOIDAL CHOROIDAL VASCULOPATHY (PCV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Personalized eye injections show promise for controlling serious vision disease

Disease control Completed

This study tested if a personalized schedule for brolucizumab eye injections works as well as a standard schedule for people with a serious eye disease called PCV. The goal was to control the disease and preserve vision while potentially giving patients fewer injections. It invol…

Matched conditions: MACULAR POLYPOIDAL CHOROIDAL VASCULOPATHY (PCV)

Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

MACULAR POLYPOIDAL CHOROIDAL VASCULOPATHY (PCV)

Get alerted when new MACULAR POLYPOIDAL CHOROIDAL VASCULOPATHY (PCV) trials appear

Personalized eye injections show promise for controlling serious vision disease